Myers Bigel is pleased to announce Chris Venters has joined the firm’s award-winning legal team as a Technical Specialist.
Prior to joining Myers Bigel, Chris partnered with a Durham-based scientific entrepreneur to help launch a biotech startup in the RTP focused on phenotypic screening for small molecule drug discovery to target RNA processing diseases. As the Lead Biologist, Chris helped to design a business plan, raise seed money, recruit a research team, and build a target identification pipeline for the screening platform.
Mr. Venters received B.S. in Biology from Duke University, where he Graduated with Distinction for his research thesis on structural studies of a Drosophila melanogaster myosin protein. He received his Ph.D. in Biology from the University of Pennsylvania, where he conducted cell and molecular research on the function of several specific spliceosomal proteins and ribonucleoproteins both in human and other model organisms. During his doctoral research, he also developed many bioinformatics workflows to examine the impact of these RNA splicing and processing proteins in various diseases using large RNA and DNA sequencing datasets.
He joins a team of attorneys and patent agents emphasizing patent procurement in practice areas including electronics/computer, mechanical, trademark, chemical and biotechnology. The firm’s experience with domestic and international patents is vast, having successfully filed in practically every country in the world, drafting quality patents that cover the full scope of an invention and stand up to courtroom challenges.